Report overview
Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as ?customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient.
This report aims to provide a comprehensive presentation of the global market for Animal Drug Compounding, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Drug Compounding. This report contains market size and forecasts of Animal Drug Compounding in global, including the following market information:
Global Animal Drug Compounding Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Animal Drug Compounding Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Animal Drug Compounding companies in 2022 (%)
The global Animal Drug Compounding market was valued at US$ 842.6 million in 2022 and is projected to reach US$ 1261.4 million by 2029, at a CAGR of 5.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Animal drug shortages are becoming more common and this is unfortunately predicted to worsen in the years ahead, as per official reports published by veterinarians. This shortage encourages the use of widely available compounded drugs to treat a number of animal diseases. A few critical animal drug shortages highlighted by the U.S. FDA are Flunixine Injectable, 35% Perox-Aid, and Epinephrine. To make medical therapy suitable for animal requirements, compounded drugs with the desired active ingredients are unavailable. For e.g., no FDA approved drug for treating megacolon in cats is currently available in the animal drug compounding market. The only safe and effective therapy to treat chronic cat constipation was removed from the U.S. nearly two decades ago. That is why compounding drugs are the only option for veterinarians to treat animals that need pro-kinetic drug therapy.
We surveyed the Animal Drug Compounding manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Animal Drug Compounding Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Animal Drug Compounding Market Segment Percentages, by Type, 2022 (%)
Anti-Infective Agents
Hormones and Substitutes
Anti-Inflammatory Agents
Others
Global Animal Drug Compounding Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Animal Drug Compounding Market Segment Percentages, by Application, 2022 (%)
Veterinary Hospitals
Veterinary Clinics
Veterinary Diagnostic Centers
Global Animal Drug Compounding Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Animal Drug Compounding Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Animal Drug Compounding revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Animal Drug Compounding revenues share in global market, 2022 (%)
Key companies Animal Drug Compounding sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Animal Drug Compounding sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Triangle Compounding Pharmacy
Lorraine's Pharmacy
Medisca
Diamondback Drugs
ESSENTIAL PHARMACY COMPOUNDING VET
Outline of Major Chapters:
Chapter 1: Introduces the definition of Animal Drug Compounding, market overview.
Chapter 2: Global Animal Drug Compounding market size in revenue and volume.
Chapter 3: Detailed analysis of Animal Drug Compounding manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Animal Drug Compounding in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Animal Drug Compounding capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
